Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers

Management of Opioid-Induced Constipation in Cancer Patients

(2012) Antonio Gatti et al.   CLINICAL DRUG INVESTIGATION

Methylnaltrexone for the treatment of opioid-induced constipation

(2012) Sabine Bader et al.   Expert Review of Gastroenterology & Hepatology

Methylnaltrexone for Treatment of Acute Colonic Pseudo-obstruction

(2011) Leonard B. Weinstock et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers

(2011) R. Ray et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Methylnaltrexone

(2010) Karly P. Garnock-Jones et al.   DRUGS

Involvement of peripheral mu opioid receptors in scratching behavior in mice

(2010) Atsuki Yamamoto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma

(2009) R. E. Kast   JOURNAL OF NEURO-ONCOLOGY

Methylnaltrexone Treatment of Opioid-Induced Constipation in Patients with Advanced Illness

(2009) Bruce H. Chamberlain et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Opioid receptors in the gastrointestinal tract

(2009) Peter Holzer   REGULATORY PEPTIDES

Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study

(2008) Russell K. Portenoy et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness

(2008) Jay Thomas et al.   NEW ENGLAND JOURNAL OF MEDICINE